-
HTA Readiness for Tumor-Agnostic Therapies: Lessons From Analogues Across Major Markets
Sep 9, 2025, 16:22 PM -
Clinical Benefit vs. Reimbursement Decisions: Examining Misalignments Between ESMO-MCBS and HTA Outcomes in Oncology
Sep 9, 2025, 16:22 PM -
Mental Health Benefits of Exercise Variation: Evidence From the 2024 5EU National Health and Wellness Survey
Sep 9, 2025, 16:22 PM -
The Incidence and Economic Impact of Major Adverse Events Associated With Intravascular Temperature Management: A Systematic Review, Analysis, and Model
Sep 9, 2025, 16:22 PM -
Understanding the Needs and Aspirations of Emerging HEOR Talent: Results From the ISPOR New Professional and Student Survey
Sep 9, 2025, 16:22 PM -
Utilization of Best-Value Medicines for Teriparatide in the Irish Healthcare Setting
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of First-Line Therapies for Microsatellite-Instability-High (MSI-H) or Mismatch-Repair-Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (mCRC) in France
Sep 9, 2025, 16:22 PM -
Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada
Sep 9, 2025, 16:22 PM -
Reducing External Plasma Dependency: Impact for the Portuguese National Health Service
Sep 9, 2025, 16:22 PM -
Quality and Impact of Real-World Data in Chronic Disease Research: Insights From Retrospective Studies Using the Hospital Episode Statistics (HES) Database
Sep 9, 2025, 16:22 PM -
From Complex Statistics to Clinically Meaningful Insights: Interpreting Results in Meta-Analyses of Continuous Outcomes
Sep 9, 2025, 16:22 PM -
Comparative Clinical Effectiveness in Skin Cancer: Lessons From HTA Decision Making in EU4, UK, and Australia
Sep 9, 2025, 16:22 PM -
Hospitalizations for Myasthenia Gravis: Pre- and Post-COVID Trends
Sep 9, 2025, 16:22 PM -
The Real-World Impact of Step Therapy and Prior Authorization on Patients, Clinicians, and US Health Plans: Lessons to Be Learned in Europe
Sep 9, 2025, 16:22 PM -
NICE Decisions in the Southwest Quadrant
Sep 9, 2025, 16:22 PM -
A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024
Sep 9, 2025, 16:22 PM -
Mental and Behavioral Health Disorders MBHD Among Patients With Metastatic and Nonmetastatic Cancer: A Claims-Based Analysis
Sep 9, 2025, 16:22 PM -
Adjuvanted RSVpreF3 Vaccine for Respiratory Syncytial Virus Prevention in the United Kingdom, Spain, and Australia: A Climate Change Impact Analysis
Sep 9, 2025, 16:22 PM -
Clinical Outcomes In HTA Appraisal Reports Of Oncology Medicines In Portugal: A Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Nalbuphine Compared With Analgesics for Moderate to Severe Postoperative Pain: A Systematic Review and Network Meta-Analysis
Sep 9, 2025, 16:22 PM
